Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.22.2.2
Summary of Significant Accounting Policies (Details 2) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,709,523 2,512,108 2,709,523 2,453,501
Employee Stock Option 1 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 290,330 96,248 290,330 37,641
Warrant 1 [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 2,419,193 2,415,860 2,419,193 2,415,860